health United States
Lawsuits filed over alleged GLP-1-related vision loss
90lawsuits
Lawsuits filed by Weitz & Luxembourg against Novo Nordisk in a New Jersey state court since 2025
Dozens of people have sued GLP-1 drug companies in the United States, alleging that the medications caused NAION, a condition that can lead to permanent vision loss. Companies and researchers dispute or remain uncertain about the alleged link.
1 sourceAl JazeeraUpdated
Claims
Support what holds up. Dispute what doesn't.
- 90lawsuits
Lawsuits filed by Weitz & Luxembourg against Novo Nordisk in a New Jersey state court since 2025
“has filed more than 90 lawsuits against Novo Nordisk in a New Jersey state court since 2025”
AllegedThe lawsuits assert that GLP-1 treatments cause nonarteritic anterior ischemic optic neuropathy
“The lawsuits asserted that the drugs cause nonarteritic anterior ischemic optic neuropathy”
It remains unclear whether GLP-1 drugs cause nonarteritic anterior ischemic optic neuropathy
“It remains unclear how or if the drug is the cause of these problems.”